LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Other Operating Assets
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Other Operating Assets of $845.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $1.05M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$209.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $90.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other operating assets for the quarter ending 2025-05-25 was -$1.61M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other operating assets for fiscal 2025 was -$378.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other operating assets for fiscal 2024 was -$2.85M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other operating assets for fiscal 2023 was -$2.16M, a 412.92% decline from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other operating assets for fiscal 2022 was $689.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 7 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $845.00K 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | -$209.00K 10-Q · filed 2026-05-06 | ||||||
| 2025-12-31 | $546.00K 10-KT · filed 2026-03-16 | ||||||
| 2025-09-30 | $90.00K 10-Q · filed 2025-11-06 | ||||||
| 2025-05-25 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.52M 10-Q · filed 2026-08-05 | -$592.00K derived: sum of 3 quarters · filed 2026-08-05 | -$378.00K 10-KT · filed 2026-03-16 | |||
| 2025-02-23 | $97.00K 10-Q · filed 2026-05-06 | $1.02M derived: sum of 2 quarters · filed 2026-05-06 | $1.24M 10-Q · filed 2025-04-03 | $366.00K derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-11-24 | $925.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | $1.14M 10-Q · filed 2025-01-02 | $269.00K derived: sum of 3 quarters · filed 2026-03-16 | $308.00K derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-08-25 | $214.00K 10-Q · filed 2025-11-06 | $244.00K 10-Q · filed 2024-10-04 | -$656.00K derived: sum of 2 quarters · filed 2026-03-16 | -$617.00K derived: sum of 3 quarters · filed 2026-03-16 | -$5.07M derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2024-05-26 | -$870.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | -$831.00K derived: sum of 2 quarters · filed 2026-03-16 | -$5.28M derived: sum of 3 quarters · filed 2026-03-16 | -$2.85M 10-KT · filed 2026-03-16 | -$2.38M 10-K · filed 2024-08-26 | ||
| 2024-02-25 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03 | -$4.41M derived: sum of 2 quarters · filed 2025-04-03 | -$1.98M 10-Q · filed 2025-04-03 | ||||
| 2023-11-26 | -$4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | -$2.02M 10-Q · filed 2025-01-02 | |||||
| 2023-08-27 | $2.43M 10-Q · filed 2024-10-04 | ||||||
| 2023-05-28 | -$2.16M 10-K · filed 2024-08-26 | ||||||
| 2022-05-29 | $689.00K 10-K · filed 2024-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |